Skip to main content
. 2020 Jul 17;117(31):18744–18753. doi: 10.1073/pnas.2002738117

Fig. 4.

Fig. 4.

MorphEUS accurately predicts pathways of action of compounds when blinded to mechanism of action. (A) cKNN profiles of broad drug categories and (B) individual drugs for compounds with anti-TB activities (unk, unknown). Each column corresponds to a different compound or treatment dose. From left to right, joint dose profile (JP) for DG167, JSF-3825, JSF-2019; high dose profile (HD) for JSF-2019; and low dose (LD) profile for JSF-2019: n = 7,300, 7,160, 7,742, 7,742, 5,150, and 2,592 respectively. The most similar drug for each MorphEUS classification is indicated by the red asterisk.